CESAR BANUELOS, PA-C
Physician Assistant in LAREDO, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CESAR BANUELOS, PA-C filed 2,251 Medicare Part D claims in 2023 as a Physician Assistant in LAREDO, Texas, prescribing 75% generic.
- 2K
- Part D claims, 2023
- 75%
- generic prescribing
- $151.29
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CESAR BANUELOS, PA-C's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
2,251 Top 15% higher than 85% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about CESAR BANUELOS, PA-C?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Physician Assistant compares to other specialties among Texas providers
Physician Assistant share within Texas
Physician Assistant is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Physician Assistant (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Physician Assistant ABMS/AOA estimate
Est. board-certified rate (Physician Assistant) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Physician Assistant US NPIs
Specialty board-certified rate — Physician Assistant estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CESAR BANUELOS, PA-C appears in the CMS NPPES registry as a Physician Assistant provider holding PA-C credentials at 1515 PAPPAS ST, LAREDO, TX, 78041, with a listed phone of (956) 523-3683. NPI 1093022568 was issued on 09/07/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BANUELOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,251 prescription claims written by this provider, covering 112 Medicare beneficiaries and totaling roughly $574K in drug spend, split 25% brand-name and 75% generic by claim count, with an opioid prescribing rate of 0.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1093022568 |
|---|---|
| Specialty | Physician Assistant |
| Credentials | PA-C |
| Gender | Male |
| NPI Issued | 09/07/2010 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CESAR BANUELOS, PA-C's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CESAR BANUELOS, PA-C. Source: openpaymentsdata.cms.gov.
Total received
$151
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to CESAR BANUELOS, PA-C. To verify CESAR BANUELOS, PA-C's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
25% brand-name claims vs 75% generic, on 2,251 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,872
- Total Day Supply
- 114,926
- Brand vs Generic
- 25% brand / 75% generic
- Brand Drug Cost
- $527K
- Generic Drug Cost
- $46K
- Opioid Claims
- 14 (0.6% rate)
Patient Demographics
- Average Patient Age
- 70.0 years
- Avg HCC Risk Score
- 1.44
- Gender Split
- 54% female / 46% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CESAR BANUELOS, PA-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
155 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
104 claims
- Levothyroxine Sodium
Levothyroxine Sodium
93 claims
- Trulicity
Trulicity
63 claims
- Metoprolol Succinate
Metoprolol Succinate
62 claims
- Duloxetine Hcl 61
Duloxetine Hcl
61 claims
- Olmesartan-Amlodip… 58
Olmesartan-Amlodipine-Hctz
58 claims
- Gabapentin 55
Gabapentin
55 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 155 |
| Rosuvastatin Calcium | 104 |
| Levothyroxine Sodium | 93 |
| Trulicity Dulaglutide | 63 |
| Metoprolol Succinate | 62 |
| Duloxetine Hcl | 61 |
| Olmesartan-Amlodipine-Hctz Olmesartan/Amlodipin/Hcthiazid | 58 |
| Gabapentin | 55 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 55 |
| Amlodipine Besylate | 53 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Physician Assistant Overview
How CESAR BANUELOS, PA-C fits within the Physician Assistant landscape nationally.
CESAR BANUELOS, PA-C's 2,251 claims are above the specialty average of 790.
Nearby Physician Assistant Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BANUELOS.
Compare Physician Assistant nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is CESAR BANUELOS, PA-C's specialty? ▼
How much does CESAR BANUELOS, PA-C prescribe under Medicare Part D? ▼
Where is CESAR BANUELOS, PA-C located? ▼
What is CESAR BANUELOS, PA-C's NPI number? ▼
Does CESAR BANUELOS, PA-C prescribe more brand-name or generic drugs? ▼
Does CESAR BANUELOS, PA-C prescribe opioids? ▼
How many Physician Assistant providers are there in the US? ▼
What drugs does CESAR BANUELOS, PA-C prescribe most often? ▼
Does CESAR BANUELOS, PA-C accept Medicare? ▼
How can I verify CESAR BANUELOS, PA-C's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology